<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 257 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page256.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=257">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 257 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 257</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=257"><img src="../thumb/257.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>220 / 2020-04                                                          Genital System - 17.2 / 17.3
   (S1) VAG CREAM, G/18.6/61. 100 mg/5 g  Indications: Post-menopaus.& senile vulvo-vaginit., atroph.vaginit.,   Indications: Prevent.of uterin.aton.follow. Caesar. sect.under epi-
   832502-006: 40 g, R396,94    prurit.vulvae caus.by. atroph.chang.in vulv.epithelium, dyspareun. as-  dur./spin.anaesthes.
   832502-014: 78 g, R589,05    soc.with atroph.vag.epithelium., prior to plast. pelv.surg.in menopaus.  (S3) INJ, A42/19/0383
   Dosage: Safety & effic.in childr.& adolesc.below 18 yrs.not stud.   (S2) CREAM, G3019. 0,625 mg/g.  718912-001: 100 µg/ml, 5 x 1 ml vials, R1 352,02
   1 applicat.(5 g)PV nightly x7 days. A second course may be given.  832448-001: 42,5 g+applicat., R202,77  Dosage: Sngl.dos.1 ml (100 µg) admin.as IV bolus aft. deliv of inft.
   Contraindications: Other imidazole derivat. hypersens.,   Dosage: Admin.cyclic: 3 wks on, 1 wk off. For short use only.  aft.caesar.sect. Use only at well equip./ exper.special.obstetr.units.
   Side effects: Genit.prurit.female, vag.burn. sensat./ discomf., dysmen-  Atroph.vaginit: Admin. low.dos.to contr.sympt. & discont. as prompt.  Contraindications: Pregn., labour bef.deliv., oxytocin & carbetocin
   orrh., vag.discharg./ -haemorrh./-pain/-irrit., headache, UTI, abdom.pain,   as poss. Usual. ½ to 2 g dly.depend. on sever.of condit.  hypersens., hepat./ren.dis., labour induct., ser.CV disords.
   naus., skin rash, dysur., rosacea, urticar., face swell., allerg.condits.incl.  Contraindications: Known/susp.pregn., undiagn. abnorm.vag.  Side effects: Anaem, thrombocytopen., allerg. reacts., confus.,
   anaphylact.& anaphylactoid reacts., angioed., prurit,. applicat. site reacts.  bleed., known/suspect./past breast Ca, known/susp.oestrog.depend.  headache., trem., dizzin., nystagm., amblyop., tinnit., arrhythm., pal-
   Warnings and special precautions: Girls und. 12 yrs.unless   neoplas., act./ hist.confirm.ven.thromboembolism, act./ recent arter.  pitat., tachycard., hypotens., flush., pall., chest/back pain, dyspn.,
   und. med.supervis., discont.if skin rash/ new irrit. occurs, appropr.  thromboembol.dis., liv.dysfunct./dis.if LFT fail.return.to norm., lactat.,   cough, hypervent., GI disords., prurit., rash, musc.cramps, breast en-
   ther.when sex. partn.infect., may decr.effectiven.of latex contracept.   safety & effic.in paed.pts.not est.  gorgem., warmth, chills, pain, inject.site react., asthen., hypotherm.,
   agents, monit. anticoag.eff.of oral anticoag./ oral hypoglycaem.&   Side effects: Incr.ovar.Ca.risk, poss.dementia in old.women., incr.  oed., sweat., abnorm.ECG.
   phenytoin, use only dur. 1  trimest.of pregn.aft. consider.benefit:risk   gallbladd.dis.risk, retin.vasc. thrombos., vis. abnormalit., hypercal-  Warnings and special precautions: Use bef. deliv. of inft.not ap-
             st
   ratio, incr.risk for spontan. abort., lactat.  caem.in breast Ca & bone metast., breakthrough bleed., spott.,   propr.as uteroton.activ.persists for sev.hrs. aft.sngl.bol.inj., consid.re-
   Drug interactions: Inhibit.CYP3A4/2C9, incr.eff.& S/E with concom.  breast tendern./pain/enlargem./discharg., applic. site reacts.of vulvo-  tain.placent. fragm./ inadeq.emptying or repair of uter./disords. of bld.
   oral hypoglycaem.& phenytoin.  vagin.discomf.incl.burn./irrit.& genit.prurit., vagin.discharg., incr.uter.   coagulat.in case of persist.uterin.bleed.aft. admin., consid.addit.ther.
   GYNO-PEVARYL, Janssen Pharmaceutica [P/S]  leiomyomata size, endometr.hyperplas., GI disturbs. incl.pancreatit.,   with other oxytocics in case of persist.uterin.hypoton./atonia, water
                                CNS effs., CVA/ stroke, arthralg., leg cramps, chang.in libido, psych.
   Econazole nitr.              disords., vasc.disords.incl.ven.thrombos., oed., alopec., skin reacts.  intoxicat., hyponatraem., recogn.early signs of drowsin./ listlessn./
   Indications: Vag.candidias.  incl.erythema multiforme/ nodosum, cholest.jaund., vaginit.incl.  headache to prev.convuls.& coma, epilep./migraine/asthma/CV dis./
   (S1) VAG.CREAM, [P/S] H/18.6/166.  vag. candidias., cystit., benign/malign.neoplasms incl. enlargem. of   states where rapid addit.to extracellul.water may produc. hazard,
   832367-001: 1 g/100 g, 78 g, R475,82  hepat.hemangiom., anaphylact./ anaphylactoid reacts.incl.urticar.&   monit.BP in eclamps.& pre-eclamps.pts.for up to 8 hrs., for IV inject.
   Dosage: 1 applic.on retir.x2 wks.                          only., admin.as soon as poss. aft.deliv.pref.bef.remov.of placenta., do
   (S1) OVULES-150 [P/S] J/18.6/176  angioed., hypersens., gluc./cont.lens intol., MI, weight chang., incr.  not mix with other infus.fluids.
                                triglycerid., incr.BP, precoc.pubert., premat.breast developm.& vagin.
   729752-003: 150 mg, 3, R245,67                             Drug interactions: Occurr.of interact.known with oxytocin cannot
   Dosage: 1 ovule nightly x3 consec.nights.  cornificat.poss. vag.bleed.induc.in prepubert. girls.  be exclud.incl.sev.hypertens. when giv. 3-4 hrs.follow.prophylact.
                                Warnings and special precautions: Incr.breast & ovar.Ca/CV dis.
   (S1) DEPOT-OVULE, [P/S] R/18.6/179                         admin.of a vasoconstrict.in conjunct.with caudal-block anaesthes.
   729841-007: 150 mg, 2, R436,36  risk, incr.endometr.Ca risk in women with intact uterus, not for card.  See also MDR page 336.
                                dis. prevent., weigh risk vs.benef.of ERT/HRT incl. emerg. risk with
   Dosage: 1 ovule on retir.    contin.ther., poss.system.absorpt., take into acc.precaut.& advers.  PRANDIN E2, Pfizer [P/S]
   Side effects: Skin burn., prurit., rash, vulvovag. burn.sensat.,   reacts.assoc.with CEE. treatm., stroke & DVT risk incr.with ERT, MI/   Dinoprostone.
   hypersens., angio-oed., urticar., cont. dermatit., skin exfoliat.,   ven,thrombos.& pulm.embol.& risk incr.with HRT, thrombot.disords.,   Indications: Labour induct.in at-term/near-term pregn. pts.where
   erythema,applic.pain/-site irrit & swell.                  there are no foet./matern.C/I.
   Warnings and special precautions: Girls und. 12 yrs., poss.decr.  discont.oestrog.4 to 6 wks.prior to maj.surg./ prolong.immobilisat.,   (S4) VAG.GEL. W/19/455, 456.
                                yearly breast exam.& mammogr.advis., reduc.endometr. hyperplas.
   effectiven.of rubber /spermicid. contracept.agents, other concom.in-  835498-026: 1 mg dose, R513,04
   tern./extern. genital. treatm., sensitiv.to imidazoles, monit. anticoag.  risk with add.progest.to oestrog. replacem. ther., discont.if sudd.loss of   835501-027: 2 mg dose, R618,72
                                vis./onset of proptos./ diplop./migraine/hypercalcaem., discont./ taper.
   eff.of warfar./other oral anticoags., safety in pregn.& lactat.not est.  Dosage: Init. 1 mg into poster.fornix of vag.canal., aft. 6 hrs.a 2nd.
   Drug interactions: Clinical.relev.interacts.report. with oral an-  of meds.to be made at 3-6 mnth. interv., excl.pregn./compl.med.hist.&   dos.of 1 or 2 mg as necess. Max: 3 mg.
                                physic./ gynae.exam.bef.start.ther., risk-benef.consid., card./ren.dys-
   ticoags.                     funct., pre-exist.hypertriglyceridaem., imp.liv.funct., cholest.jaund.hist.,   Contra-indications: Grand multiparity (5 or more), no engagem.of
   LOMEXIN, Litha [P/S]         advers.effs.on lipoprot.metabol., reg.BP monit., asthma/epilep./ mi-  the head, prev.uter.surg., cephalopelv. disproport., foetal heart rate
   Fenticonazole                graine/ diab.mellit./porphyr./SLE & hepat. hemangiom., endometrios.  pattern suggest.incipient foetal compromise, obstet. condit. where
   Indications: Vulvo vagin.candidias.  exacerb., sev. hypocalcaem., hypothyroid., developm.abnorm. uterine   matern./foet.benef.vs.risk favours surg.intervent., unexplain.vag.dis-
   (S3) CREAM, 29/18.6/0055     bleed., weaken.& contrib.to condom fail., do not start ther.bef.epiphys.  charge/uter./vag. bleed.dur.curr.pregn., concom.oxytoc.
   833908-006: 100 mg/5 g, 30 g, R152,69  clos.has occur., high. stroke/ breast Ca risk in women over 75 yrs.  Side-effects: Alter.foetal heart rate patterns diagn. as foetal dis-
   Dosage: Admin.5 g PV every morn.& even.x3 days  Drug interactions: Poss.reduc.plasma conc.with strong CYP3A4   tress, uter.hypercontract./ hyperton, N&V, diarrh., low.BP, back pain,
   (S3) OVULES, 29/18.6/0053, 0054  inducers, poss.incr.plasma conc. with CYP3A4 inhibits.  still birth, warm feel.in vag., fev., hypersens.reacts.
   833916-009: 200 mg, 3, R169,20                             Special precautions: Contin.electron.monit.of uter.activ.&foet.
   833924-001: 600 mg, 1, R169,20  SYNAPAUSE, (Aspen Pharmacare)    heart rate dur.lab induct., compromis. CV/hepat./ren.funct., asthma,
   Dosage: 200 mg PV in even.x3 days or 600 mg as sngl.dos.  Pharmacare [P/S]  consider. uter.rupt.in the pres.of excess.uter.activ. / unusual uterine
   Contraindications: Imidazole hypersens., safety in pregn.& lactat.  Estriol  pain, allow 6 hr.interv.bef. sequent. use of oxytocin, multiple gestat.,
   not est., not recomm.for childr.  Indications: HRT for treatm.of low.urogenital tract atrophy relat.to   chorioamniot. membr.rupt., glauc., rais.IOP, eval. clinic.situat.& instit.
   Side effects: Less freq: Mild & trans.erythemat. reacts., burn.  oestrog.defic.assoc.with natur/ surg.menopause, pre-& postop ther.  suit.meas.if uterine hypertonus/ hypercontractilil./where abnorm.
   sensat., allerg.reacts.      in postmenopaus/ ovariectom.women undergo.vag. surg.  foet. heart patterns.devel.
   Warnings and special precautions: Treat sex.partners with   (S2) VAG CREAM, V/18.6/201. 1 mg/g  Drug interactions: Oxytocin respons.accent.in pres. of exogen.
   loc.with cream., discont. in event of hypersens.reacts./resist.mi-  832464-007: 15 g, R193,71  prostagland.ther.
   croorgan.developm.           Dosage: Admin.intravag.bef.retir.at night. One applic.till ring
   Interactions: Add.contracept.meas. necess.dur. loc. admin.due to   mark =0,5 mg.  PROPESS, Ferring [P/S] &
   poss.damag.of latex contracept.,  Low.urogenit.tract atrophy: 1applic/day x1st 2-3 wks. Follow.  Dinoprostone  th
                                with grad.reduct.bas.on sympt relief until maint.dos.of 1 applc.2x/
                                                              Indications: Init./continuat.of cervic. ripen.from 38  wk.with Bishop
   MEDASPOR, Cipla Medpro [P/S]  wk.achiev.                   score of 6 or less.
   Clotrimazole.                Pre- & post-op ther: 1 applic./day x2 wks.bef. surg. 1 applic.2x/wk   (S4) VAG.INSERT, 33/19/0059. 10 mg/unit
   Indications: Fung.vaginit./vulvovaginit.mainly Candida.  x2wks.aft.surg. Commence post surg.treatm.as soon as applic.poss.  702183-003: 5, R5 778,90
   (S2) VAG.CREAM. 27/20.2.2/0285. 10 mg/g.  Contraindications: Ca breast known/susp.or hist. thereof,   Dosage: Insert one, high into posterior vag. fornix. If aft.12 hrs.cer-
   832391-018: 50 g+8 vag.applicat., R39,15  oestrog.depend.malign.tumours., undiagn. vag.bleed., untreat.  vic.ripen.is insuffic.remove insert. A replacem.second insert may be
   Dosage: Insert 5 g PV.bef.retir.x6 consec.days. Two applicl./day   endometr.hyperplas., prev. idiopath./curr./risk fact.for ven.thrombo-  admin.which must also be remov.no more than 12 hrs.later. Ther.
   x6-12 days if necess. Treat. partn. loc.at same time to prev.reinfect.  embol., known thrombophil.disords., pregn.& lactat., act./recent   should not involv.more than 2 inserts. Pt.to remain in recumb.posit.
   Vulvit./vulvo-vaginit: apply thinly to ext.genital. 2-3xdly x1-2 wks.  arter.thromboembol.dis., ac.liv. dis/ hist.of liv.dis.as long as LFT fail.  for 20-30 mins. Remov.insert when ripen.judged complete or at onset
   Contraindications: Safety in pregn.not est.  return.to norm., porphyr.  of labour, spontan. membr.rupture/amniotomy, uterine hyperstimulat.,
   Side effects: Loc.reacts., low abdom.cramps, incr. urin.freq./skin   Side effects: Endometrial Ca, dement., gall bladd.dis., loc.irrit.& itch.,   hyperton.uter.contract., foet. distress, matern.system. PGE 2 adverse
   rash in syst.absorpt.        chloasma/melasma, erythema multiforme &-nodosum, vasc.purpura,   effs.at the start of IV oxytocin infus.
   METROGEL V, iNova [P/S]      breast tens./tendern & enlargem., breakthrough bleed./spott., cervic.  Contraindications: Do not insert/leave in place when labour
                                discharge, endometrial hyperplas.
   Metronidazole                Warnings and special precautions: Phys. exam./compl.med.&   start., membr.ruptur., oxytocic drugs admin., pts.unsuit.to prolong.
   Indications: Bact.vaginosis  fam.hist.bef.init.ther.& per. indiv.check-ups, condits.poss.recur/ag-  contracts., prev.maj. uterine surg., prev.cervic./uter.surg., maj.degr.
   (S2) VAG.GEL, 33/20.2.6/0243. 37,5 mg/5 g  grav: leiomyoma/ endometrios./hist.of /risk facts.for thromboembol.   of cephalopelv.disproport., curr.pelv. inflammat.dis. unless treatm.
   706439-001: 40 g+5x5 g vag.applicat., R228,39  disords.or oestrog.depend.tumours, hypertens./ liv.disords./diab.mel-  instit., multiple pregn., PGE 2 hypersens .
   Dosage: Not recomm.dur.menses.                             Side effects: Effs.are dos.& route of admin. relat. Cardiotoco-
   1 applicat.full (i.e. 5 g) into vagina once dly at bedt.x5 days.  lit.with/without vasc. involvem./cholelithias./migraine or sev. head-  graph changes & unspecif.foet. distress, incr.uter.activ.with hyper-
                                ache/ SLE/endometrial hyperplas.hist./ epilep./ asthma/otoscleros.,
   Contraindications: Other nitroimidazole/ parabens sensitiv., pregn.,   ton.contract. with/out foet. distress, GI disturbs., ductus arteriosus
   safety & effectiven.in childr. not est.  discont.ther.in case of jaund./ liv.funct.deteriorat./signif.BP incr/new   potency in pregn.
                                onset of migraine type headache/pregn., endometr. hyperplas.and
   Side effects: Vag.candidias., vulvovag.itch./ burn.or swell., incr.pelv.  Special precautions: Monit.foetus & uter. activ., prev.hist of uter.
   press., abnorm.vag. discharge, GI disturbs., metallic.taste, decr./ incr.   cancer, investig.any vag. bleed., mammograph.density incr.complicat.   hypertony/glauc./asthma, discont. all NSAID’S or aspirin ther.bef.
                                radiolog. breast Ca detect.& risk lev.relat.to ther. durat., incr.breast Ca/
   WBC, headache, dizzin., gen.rash/prurit., inco-ordinat., insomn., flush.,   admin., lung/liv./ ren.dis.
   cystit., incontin., taste modificat., seiz., periph.neuropathy,  VTE risk with HRT ther., breast Ca risk incr.when progesterone add.,   Drug interactions: Potent.oxytoc.drug effs.
                                consid. prophylact.VTE meas.follow.surg., concom. anticoag.treatm.,
   Warnings and special precautions: Excret. into breast milk, re-  See also MDR page 343.
   acts. report.with oral admin. poss., ren.fail., presentat.of prev.known/  discont.if VTE develops & pts.to report potent. thromboembol.sympts.,   PROSTIN E 2 0,5 mg, Pfizer [P/S]
                                incr.risk of ovarian Ca with oestrog.only HRT products in hysterec-
   or prev.unknown candidias., bld.dyscras., CNS dis., caref. benefit   Dinoprostone.
   vis risk assesm.in Cockayne syndr. using only if not alternat.treatm.  tom. women, card./ren.dysfunct., stroke risk with HRT incr.with age.
   avail.& then perform. liv.funct.tests prior/dur.& at end of treatm., in   Indications: Induct.of labour where no foet./ matern. contraindicat.
   Cockayne syndr.discont.if liv.funct. becomes mark.elev.& pts.to re-  (S4) TABS. J/19/8.
   port sympts.of potent. liv.injury, poss.disulfiram-like react.as assoc.   17.3  Oxytocics  757810-004: 0,5 mg, 10, R655,47
   with oral admin., taper/discont.concom.Li bef.init.ther., anticoag.ther.  Dosage: Not for vag.use. Adapt to pts.respons.& maint. at low.
   Interactions: Poss.Li retent., anticoag. eff. of warfar.& other coumar.  PABAL (MDR Listing)  eff.dos.
   anticoags.potent. with oral ther.  PROPESS (MDR Listing)   Init. 0,5 mg hrly.to a max.single dos.of 1 -1,5 mg till satisfact.respons.,
                                                              then 0,5 mg hrly.for not more than 2 days.
   PREMARIN, Pfizer [P/S]       PABAL, Ferring [P/S] &        Contraindications: Sens.to prostagland., pts. unsuit. to prolong.
   Conjug.oestrog.              Carbetocin.                   contracts.e.g. prev.uter.surg./ caesar. sect./cephalopelv.disproport./</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page256.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page252.html">252</a>&nbsp;&nbsp;&nbsp;<a href="page253.html">253</a>&nbsp;&nbsp;&nbsp;<a href="page254.html">254</a>&nbsp;&nbsp;&nbsp;<a href="page255.html">255</a>&nbsp;&nbsp;&nbsp;<a href="page256.html">256</a>&nbsp;&nbsp;&nbsp;<a href="page257.html">257</a>&nbsp;&nbsp;&nbsp;<a href="page258.html">258</a>&nbsp;&nbsp;&nbsp;<a href="page259.html">259</a>&nbsp;&nbsp;&nbsp;<a href="page260.html">260</a>&nbsp;&nbsp;&nbsp;<a href="page261.html">261</a>&nbsp;&nbsp;&nbsp;<a href="page262.html">262</a>
             </td>
             <td width="35%"><a href="page258.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page258.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
